Cargando…

Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients

PURPOSE: This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent operations in our center. METHODS: This was a retrospective longitudinal analysis. We categorized the DTC patients on the basis of various lymph node (LN) charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, C, He, Q, Du, R, Zhang, D, Li, F, Dionigi, G, Liang, N, Sun, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040862/
https://www.ncbi.nlm.nih.gov/pubmed/31961797
http://dx.doi.org/10.1530/EC-20-0019
_version_ 1783501078367567872
author Sui, C
He, Q
Du, R
Zhang, D
Li, F
Dionigi, G
Liang, N
Sun, H
author_facet Sui, C
He, Q
Du, R
Zhang, D
Li, F
Dionigi, G
Liang, N
Sun, H
author_sort Sui, C
collection PubMed
description PURPOSE: This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent operations in our center. METHODS: This was a retrospective longitudinal analysis. We categorized the DTC patients on the basis of various lymph node (LN) characteristics. Logistic regression models and multiple linear regression models were used for the correlation analysis. RESULTS: A total of 3693 (58.8%) N1a patients and 2586 (41.2%) N1b patients were included. Patients with N1b disease had larger metastatic foci (0.5 vs 0.15 cm), a greater number of metastatic LNs (5 vs 2), a greater number of dissected LNs (25 vs 7), and a smaller lymph node ratio (NR, number of positive LNs/number of sampled LNs) (23.1% vs 28.6%) than patients in stage N1a. Comparing the clinicopathological features, we found that male, increased tumor size, multifocality, and thyroiditis increased the risk of stage N1b disease (P < 0.05). Sex, multifocality, capsular infiltration, and tumor size were associated with the size of the metastatic LNs (P < 0.05). Sex, capsular infiltration, and nodular goiter were associated with the NR (P < 0.05). Female sex, tumor located in inferior lobe, maximal tumor diameter (MTD) < 1 cm, and nodular goiter were independent predictors for skip metastases (P < 0.05). MTD > 1 cm, central neck metastasis and age were independent predictors for bilateral lateral neck metastasis (BLNM) (P < 0.05). CONCLUSION: The LN characteristics of stage N1a and N1b disease were associated with significantly different features, such as sex, tumor size, multifocality, capsular infiltration, and nodular goiter.
format Online
Article
Text
id pubmed-7040862
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-70408622020-02-27 Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients Sui, C He, Q Du, R Zhang, D Li, F Dionigi, G Liang, N Sun, H Endocr Connect Research PURPOSE: This study examined the clinicopathological characteristics of 6279 N1 differentiated thyroid cancer (DTC) patients who underwent operations in our center. METHODS: This was a retrospective longitudinal analysis. We categorized the DTC patients on the basis of various lymph node (LN) characteristics. Logistic regression models and multiple linear regression models were used for the correlation analysis. RESULTS: A total of 3693 (58.8%) N1a patients and 2586 (41.2%) N1b patients were included. Patients with N1b disease had larger metastatic foci (0.5 vs 0.15 cm), a greater number of metastatic LNs (5 vs 2), a greater number of dissected LNs (25 vs 7), and a smaller lymph node ratio (NR, number of positive LNs/number of sampled LNs) (23.1% vs 28.6%) than patients in stage N1a. Comparing the clinicopathological features, we found that male, increased tumor size, multifocality, and thyroiditis increased the risk of stage N1b disease (P < 0.05). Sex, multifocality, capsular infiltration, and tumor size were associated with the size of the metastatic LNs (P < 0.05). Sex, capsular infiltration, and nodular goiter were associated with the NR (P < 0.05). Female sex, tumor located in inferior lobe, maximal tumor diameter (MTD) < 1 cm, and nodular goiter were independent predictors for skip metastases (P < 0.05). MTD > 1 cm, central neck metastasis and age were independent predictors for bilateral lateral neck metastasis (BLNM) (P < 0.05). CONCLUSION: The LN characteristics of stage N1a and N1b disease were associated with significantly different features, such as sex, tumor size, multifocality, capsular infiltration, and nodular goiter. Bioscientifica Ltd 2020-01-20 /pmc/articles/PMC7040862/ /pubmed/31961797 http://dx.doi.org/10.1530/EC-20-0019 Text en © 2020 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Research
Sui, C
He, Q
Du, R
Zhang, D
Li, F
Dionigi, G
Liang, N
Sun, H
Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title_full Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title_fullStr Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title_full_unstemmed Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title_short Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
title_sort lymph node characteristics of 6279 n1 differentiated thyroid cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040862/
https://www.ncbi.nlm.nih.gov/pubmed/31961797
http://dx.doi.org/10.1530/EC-20-0019
work_keys_str_mv AT suic lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT heq lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT dur lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT zhangd lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT lif lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT dionigig lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT liangn lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients
AT sunh lymphnodecharacteristicsof6279n1differentiatedthyroidcancerpatients